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Running Title: Mechanisms of Chromosomal Instability in Ovarian Cancer 
 
Abstract 
Chromosomal instability (CIN) comprises continual gain and loss of chromosomes or parts of 
chromosomes and occurs in the majority of cancers, often conferring poor prognosis. Due to a 
scarcity of functional studies and poor understanding of how genetic or gene expression 
landscapes connect to specific CIN mechanisms, causes of CIN in most cancer types remain 
unknown. High-grade serous ovarian carcinoma (HGSC), the most common subtype of ovarian 
cancer, is the major cause of death due to gynaecological malignancy in the Western world, with 
chemotherapy resistance developing in almost all patients. HGSC exhibits high rates of 
chromosomal aberrations and knowledge of causative mechanisms would represent an important 
step towards combating this disease. Here we perform the first in-depth functional 
characterization of mechanisms driving CIN in HGSC in seven cell lines that accurately 
recapitulate HGSC genetics. Multiple mechanisms co-existed to drive CIN in HGSC, including 
elevated microtubule dynamics and DNA replication stress that can be partially rescued to 
reduce CIN by low doses of paclitaxel and nucleoside supplementation, respectively. Distinct 
CIN mechanisms indicated relationships with HGSC-relevant therapy including Poly (ADP-
Ribose) Polymerase (PARP) inhibition and microtubule-targeting agents. Comprehensive 
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genomic and transcriptomic profiling revealed deregulation of various genes involved in genome 
stability but were not directly predictive of specific CIN mechanisms, underscoring the 
importance of functional characterization to identify causes of CIN. Overall, we show that 
HGSC CIN is complex and suggest that specific CIN mechanisms could be used as functional 
biomarkers to indicate appropriate therapy. 
 
Statement of Significance 
Findings characterize multiple deregulated mechanisms of genome stability that lead to 
chromosomal instability in ovarian cancer and demonstrate the benefit of integrating analysis of 
said mechanisms into predictions of therapy response. 
 
Introduction  
The vast majority of solid tumours exhibit chromosomal instability (CIN), the continual gain 
and loss of chromosomes or parts of chromosomes1,2. CIN can drive tumour heterogeneity and 
clonal evolution, and is thought to contribute to chemotherapy resistance in many cancer types 
including ovarian cancer3,4. Knowledge of the defective cellular pathways that underlie CIN 
would enable strategies to target cancer cells using synthetic lethal or CIN-limiting approaches5, 
in addition to providing new diagnostic or prognostic tools. However, to date the causes of CIN 
in cancer remain ill-defined. Defective chromosome attachment to the mitotic spindle due to 
aberrant mitotic microtubule dynamics can contribute to CIN in cancer cell lines6-9, potentially 
driven by alterations in spindle protein abundances6 or genetic alterations in Aurora A, BRCA1 
or Chk29. Loss of retinoblastoma protein (pRB) leading to cohesion defects and CIN has been 
demonstrated in a sarcoma cell line10. Studies classifying CIN mechanisms in representative, 
cancer specific cell line panels are currently limited to colorectal cancer8,11where both DNA 
replication stress (the slowing or stalling of DNA replication) and elevated microtubule 
assembly rates were shown to contribute to CIN8,11.  
High-grade serous ovarian carcinoma (HGSC) represents an important clinical challenge; 
despite initial positive responses to first-line platinum therapy, most patients relapse, leading to 
a poor overall survival for this disease12. The genomes from both HGSC patient tumours3,13,14 
and ascites-derived HGSC cells15 bear the scars of chromosomal instability as evidenced by 
highly aberrant genomic landscapes3,13,14 (Figure S1a). There has been extensive interest in 
inferring potential cancer mutational mechanisms tumour and cancer cell line genomes, at both 
single nucleotide variant16 and chromosome-scale aberrations, particularly in ovarian cancer17,18. 
However, apart from a high prevalence of mutations in homologous recombination (HR) genes, 
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and near ubiquitous TP53 mutations13, genetic drivers of CIN remain to be elucidated in HGSC. 
Moreover, it has been shown that BRCA-mutated tumours can acquire HR reactivating 
mutations19, highlighting the need for functional analysis in defining ongoing CIN mechanisms. 
Genetic aberrations that may contribute to CIN in HGSC are Aurora A amplification and Cyclin 
E (CCNE1) amplification20. Overexpression of Cyclin E is linked to worse patient outcome21 
with combined high CCNE1 expression and genomic amplification exhibiting higher genomic 
instability22. RB1 mutations are also present in 17.5% HGSC tumours14.  
To date, functional characterisation using appropriate cell line models for HGSC is lacking. 
Recent advances including genomic approaches have defined multiple distinct subtypes of 
ovarian cancer, and have allowed the classification of available tumour-derived cell lines into 
suitable models23-25. We therefore undertook the first comprehensive functional characterisation 
of a curated panel of HGSC cell lines to define mechanisms driving chromosomal instability. 
We demonstrate that all cell lines exhibit extensive, ongoing CIN in the form of high rates of 
numerical and structural chromosome defects, and chromosome segregation errors. We find 
gross defects in multiple pathways controlling chromosome stability, and that either suppressing 
microtubule dynamics using low doses of paclitaxel, or limiting replication stress using 
nucleoside supplementation, reduces chromosome segregation errors and CIN. Furthermore, we 
show that functional analysis of CIN rates and types can inform sensitivity to standard therapies 
relevant to HGSC. In-depth genomic and gene expression analyses revealed potential genome 
stability regulators correlated with specific CIN mechanisms, or responses to therapy, providing 
a platform to investigate these associations in patient datasets. These new insights provide a first 
step towards designing new approaches to treat high-grade serous ovarian carcinoma, including 
determining whether limiting CIN could prevent CIN-driven chemotherapy resistance in 
HGSC5, and guiding development of biomarkers for appropriate therapy choices. 
 
Materials and Methods 
 
Cell Lines: HGSC and fallopian cell lines were sourced as detailed in Table S1 and maintained 
at 37°C and 5% CO2. Their identities were confirmed by STR profiling (ATCC) . HCT116, 
SW620 (kind gift from C. Swanton) and Cov318 were maintained in DMEM High Glucose 
(Sigma); Kuramochi, G33, Ovkate, Ovsaho and Snu119 were maintained in RPMI (Sigma); All 
medium was supplemented with 10% FBS and 100 U Penicillin/Streptomycin. G164 cells were 
grown in DMEM F12 (Sigma) supplemented with 5% human serum (H4522, Sigma) and 100 U 
Penicillin/Streptomycin. FNE1/FNE2 were maintained in FOMI media (University of Miami) 
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supplemented with cholera toxin (C8052, Sigma). H2B-RFP stable cell lines were generated 
after transfection with lentiviral construct H2B-RFP (Addgene 26001) and flow sorting RFP-
positive cells. Cells were routinely tested for mycoplasma using MycoAlert PLUS Mycoplasma 
Detection Kit (LT07-710, Lonza) and visual inspection using DAPI staining at the microscope. 
Cells were passaged for a maximum of 8-12 weeks (approx. 10-14 passages).  
 
Proliferation assays: Cells were seeded into 96-well dishes. The next day, additional media was 
added, supplemented with either Embryomax nucleosides (final concentration of 10x) or low-
dose paclitaxel (final concentration of 1 nM) or chemotherapy agents (at indicated final 
concentrations). Plates were imaged over the course of one week using an IncuCyte® live cell 
analysis system to calculate the percentage of confluency over time. The fold-change in 
confluency as a growth ratio (final confluency / starting confluency for that cell line grown under 
that condition) was reported.  
Metaphase spreads: Cells were arrested in colcemid for two hours, collected then re-suspended 
in hypotonic solution (0.2% KCl, 0.2% Sodium Citrate) for 7 min at 37°C. Cells were pelleted 
and re-suspended in freshly-prepared 3:1 methanol-glacial acetic acid, then dropped onto slides.  
 
Clonal FISH: Cells were seeded onto slides at low density to ensure growth of colonies from 
single cells. Colonies were grown with/without nucleosides for four weeks then fixed for 
fluorescence in-situ hybridisation (FISH). Cells in each colony were imaged and scored for 
centromere number, and percentage cells deviating from modal value for centromere of that 
colony was calculated.  
Small molecule inhibitors: 100x Embryomax nucleosides (ES-008-D, Merck Millipore) were 
diluted in medium to 10x final concentration. Taxol (Paclitaxel, P045, Cambridge Bioscience) 
was dissolved in DMSO and used at 1 nM final concentration for low-dose rescue of CIN, or at 
higher doses for chemotherapy response. Monastrol (Sigma) was dissolved in DMSO and used 
at 100 µM. Olaparib (AZD2281, Gmbh) was dissolved in DMSO. 
 
Immunofluorescence: Cells grown on coverslips were fixed with PTEMF (0.2% Triton X-100, 
0.02 M PIPES (pH 6.8), 0.01 M EGTA, 1 mM MgCl2, 4% formaldehyde). After blocking with 
3% BSA, cells were incubated with primary antibodies according to suppliers’ instructions. 
Antibodies were obtained from Abcam (Beta-tubulin (ab6046), CenpA (ab13939), Centrin 3 
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(ab54531), Cyclin A2 (ab16726), Hec1 (ab3613), RPA (ab79398)), Antibodies Incorporated 
(CREST (15-234-0001)), Bethyl Lab (Mad2 (A300 -300A)), Millipore (H2AX (05-636)), Santa 
Cruz (53BP1 (sc-22760) and Rad51 (sc-398587). Secondary antibodies used were goat anti-
mouse AlexaFluor 488 (A11017, Invitrogen), goat anti-rabbit AF594, AF488 (A11012, A11008, 
Invitrogen), and goat anti-human AF647 (109-606-088-JIR, Stratech or A21445, Invitrogen). 
DNA was stained with DAPI (Roche) and coverslips mounted in Vectashield (Vector H-1000, 
Vector Laboratories). 
 
FISH: Fluorescent In Situ Hybridisation was carried out according to manufacturer’s 
instructions. In brief, cells on slides were fixed in 3:1 methanol:acetic acid, then put through an 
ethanol dehydration series (2 minutes in 70, 90, 100% ethanol) then air dried. Probe was added 
to slides which were heated to 72°C for 2 minutes, then left at 37°C overnight in a humid 
chamber. The next day, slides were washed in 0.25x SSC at 72°C for 2 minutes, then 2xSSC, 
0.01% Tween at RT for 30 s. Slides were stained with DAPI then coverslips were mounted with 
Vectashield. Pan-centromere probe was purchased from Cambio (1695-F-02) and Centromere 
Enumeration Probes from Cytocell. 
 
M-FISH: Metaphase spreads from each cell line were hybridised with the M-FISH probe kit 
24XCyte (Zeiss MetaSystems) following the manufacturer’s instructions. Briefly, the slides 
were incubated 30 minutes in 2xSSC buffer at 70°C, then allowed to cool at room temperature 
for 20 minutes. Following a 1 minute wash in 0.1XSSC, the cells were denatured in NaOH 0.07 
M for 1 minute, then washed in 0.1xSSC, and 2xSSC. The cells were dehydrated in an ethanol 
series, and air dried. The probe mix was denatured at 75 °C for 5 min, and pre-annealed at 37°C 
for 30 min. 6 µl of probe mix were applied to each slide, under a 18x18mm coverslip. The slides 
were incubated for 3 days at 37°C, then washed for 2 minutes in 0.4xSSC, at 72°C, and 30 s in 
2xSSC, 0.05% Tween20, at room temperature, and finally mounted in DAPI/Vectashield 
(VectorLabs).  Images were acquired on an Olympus BX-51 microscope for epifluorescence 
equipped with a JAI CVM4+ progressive-scan CCD camera, and analysed using the Leica 
Cytovision Genus v7.1 software (Leica). A minimum of 25 metaphases were karyotyped for 
each cell line. 
 
Fibre Assay: Fibres were prepared as described26. In brief, cells were pulse labelled with 25µM 
CldU and 250µM IdU (Sigma) for 20 min. Cells were harvested and then lysed using 0.5% SDS, 
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20mM Tris-HCl pH 7.4, 50mM EDTA. Fibres were spread on slides and DNA detected using 
rat anti-BrdU and CldU, with secondary antibodies as above.  
 
Microscopy: Images were acquired using an Olympus DeltaVision RT microscope (Applied 
Precision, LLC) equipped with a Coolsnap HQ camera. Three-dimensional image stacks were 
acquired in 0.2 µm steps, using Olympus 100× (1.4 numerical aperture), 60× or 40× UPlanSApo 
oil immersion objectives. Deconvolution of image stacks and quantitative measurements was 
performed with SoftWorx Explorer (Applied Precision, LLC). H2B-RFP-labelled cells were live 
imaged in 4 well imaging dish (Greiner Bio-one). 20 µm z-stacks (10 images) were acquired 
using an Olympus 40× 1.3 numerical aperture UPlanSApo oil immersion objective every 3 min 
for 8 h using a DeltaVision microscope in a temperature and CO2-controlled chamber. Analysis 
was performed using Softworx Explorer. Microtubule assembly assays (see below) were 
performed in part using an Eclipse Ti-E inverted microscope (Nikon) equipped with a CSU-X1 
Zyla 4.2 camera (Ti-E, Zyla; Andor), including a Yokogawa Spinning Disk, a precision 
motorized stage, and Nikon Perfect Focus, all controlled by NIS-Elements Software (Nikon)). 
 
Microtubule dynamics assay: Microtubule dynamics were analysed as described previously8. 
Briefly, assembly rates were calculated by tracking EB3-GFP protein foci in living cells. Cells 
were seeded onto glass-bottom dishes and transduced with virus containing pEGFP_EB3 (gift 
from S. Godinho) Cells were treated with Eg5 (Kif11) inhibitor monastrol (67 µM, Sigma) for 
2 hr. Cells were then imaged on the DeltaVision microscope or using an Eclipse Ti-E inverted 
microscope (Nikon). Cells were imaged every 2 s using four sections with a Z-optical spacing 
of 0.4 µm. Average assembly rates (micrometres per minute) were calculated using data for 20 
individual microtubules per cell for 10-20 cells.  
 
Western blotting: Cell lysates were prepared using lysis buffer (20 mM Tris-HCl (pH 7.4), 135 
mM NaCl, 1.5 mM MgCl2, Triton 1%, Glycerol 10%, 1x Protease inhibitor (Roche)). 
Immunoblots were probed with antibodies against p53 (Santa Cruz sc126), Aurora A (Cell 
Signaling 12100), Vinculin (Cambridge Bioscience 66305) and cyclin E (Abcam ab3927) and 
developed using goat anti-mouse (Cell Signalling 7076S) or goat anti-rabbit (Santa Cruz sc-
2004)  IgG HRP conjugated antibodies, using a Chemidoc (GE Healthcare). 
 
Rad51 response to IR: Cells were treated using an industrial cabinet X-ray device (RS-2000, 
Rad Source Technologies) for specific times calibrated to deliver 2Gy ionizing radiation and 
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then fixed after 2 or 24 h recovery before immunofluorescence with antibodies against Cyclin A 
and Rad51.  
 
Flow cytometry: Cells were fixed in 4% formaldehyde for 7 min, permeabilised with 0.2% 
Triton X-100 for 2 min, stained with DAPI, and analysed using BD FACS Diva 8.2. RPE1 cells 
were used to calibrate FACS analysis to generate a profile for DNA signal peaks, corresponding 
to a diploid cell line. RPE1-H2B-RFP and parental RPE1 cells were then mixed and analysed 
together, for a direct comparison, to verify that H2B tagging did not alter the expected peaks. 
RPE1-H2B-RFP cells were then mixed with known near-diploid or aneuploid cell lines 
(HCT116 and SW1116) to verify that the FACS analysis could distinguish that RFP positive 
cells gave the expected profile compared to the RFP-negative cells when analysed together. 
RPE1-H2B-RFP cells were then mixed with individual HGSC cell lines, to determine whether 
each HGSC cell line overlapped the diploid DNA signature or differed, indicating aneuploidy.  
 
Whole Genome Sequencing: Sample processing and whole genome sequencing were carried 
out by Edinburgh Genomics. Samples were processed using Illumina TruSeq Nano libraries. and 
sequenced with Illumina HiSeq X instruments to an average depth coverage of 30X. Due to the 
nature of our cell line samples, matched normal tissue/blood samples were unavailable for 
analysis. For further details including downsampling and absolute copy number estimation, 
somatic mutation and copy number variation, and cancer genome breakpoint analysis methods 
see Supplementary Methods.  
 
RNAseq Analysis: RNA was extracted from cell lines using RNEasy kits (Qiagen) for three 
biological repeats. RNA-seq was performed by Bart's and the London Genome Centre on the 
Illumina NextSeq 500 platform, generating on average ~1.5 million single-end reads of 75 bp in 
length per sample. For analysis methods see Supplementary Methods.  
 
Statistical Analysis: Statistical tests were carried out where indicated in figure legends, as either 
an unpaired t-test with Welch’s correction, or a one-way ANOVA with Dunnett’s multiple 
comparison (every cell line compared to FNE1). Asterisks denote the significance value between 
experimental conditions adhering to the following nomenclature: p<0.05 (*); p<0.01 (**); 
p<0.001 (***); p<0.0001 (****). For values close to p=0.05, actual p-values are given. All 





Numerical and structural chromosome defects, and persistent chromosome segregation 
errors in HGSC cell lines. 
Cancer-derived cell lines have proven a useful resource to investigate ongoing 
mechanisms driving chromosomal instability6,8,11,27. We assembled a panel of seven HGSC lines, 
five from the top ten suitable cell line models for HGSC (Cov318, Kuramochi, Ovkate, Ovsaho, 
Snu119)23 and two obtained from recent confirmed HGSC patients (G3328 and G164) (Table 
S1). As tissue-type specific controls, we obtained two, h-TERT-immortalised fallopian tube 
serous epithelial cell lines (FNE1 and FNE229), representing the likely tissue of origin of 
HGSC30. We performed whole genome sequencing (Methods) to characterize the extent of 
genomic alteration in the HGSC lines. First, to visualise genomic gains and losses, we performed 
copy number segmentation and computed the DNA copy number profiles (Figure 1a; see 
Methods for details). Similar to HGSC genomes available in the TGCA dataset13,23, the HGSC 
lines displayed complex copy number profiles (Figure 1a). Our analysis also computed the most 
likely models of ploidy (Figure S1b), and we further confirmed these using chromosome 
counting from metaphase chromosome spreads (Figure 1b,c, Figure S1c) and FACS ploidy 
analyses (Figure S1d). There was a notable range in ploidy between cell lines, varying between 
near-diploid (2n) to near-tetraploid (4n) (Figure 1c). To examine chromosome alterations at a 
single-cell level, we performed multiplex-FISH (M-FISH) on metaphase chromosome spreads 
for FNE1 and Kuramochi cell lines. As expected, FNE1 were near diploid (Figure 1d; Table 
S1). By contrast, Kuramochi cells displayed a high prevalence of numerical and structural 
alterations that were highly heterogeneous between individual cells (Figure 1d and Figure S1e). 
Metaphase chromosome spreads analysed with centromeric fluorescence in-situ hybridisation 
(FISH) probes also demonstrated the presence of structural chromosome aberrations (dicentric 
and acentric chromosomes) in all HGSC cell lines (Figure S1f).  
We next analysed genetic mutations relevant to HGSC. We verified the known BRCA2 
non-sense mutation in Kuramochi23, but did not identify any BRCA1/2 mutations of known 
pathogenicity in other cell lines (Table S2; Figure S5a). Some lines exhibited BRCA1 or BRCA2 
copy number alteration (Figure S1j) although gene expression was not significantly altered 
compared to the FNE controls except for BRCA2 in Ovsaho (Figure S1g, S5c). TP53 mutations 
occur in 96% of HGSC tumours13. Accordingly, all seven HGSC cell lines exhibited TP53 
mutations and aberrant p53 protein expression (including premature stop codons in G33 and 
Ovsaho) compared to FNE1 cells (Figure S1h,j, Table S2). Five cell lines demonstrated CCNE1 
copy number gain and corresponding changes in RNA expression, and all seven lines showed 
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overexpression at protein level compared to FNE1 (Figure S1i,j). Our HGSC cell line panel thus 
recapitulates key genomic features of HGSC tumours, and encompasses a range of ploidy and 
genomic alterations.  
The diversity of chromosome alterations between individual Kuramochi cells, and the 
prevalence of structural and numerical chromosome alterations in all HGSC lines, suggested that 
chromosomal instability was ongoing. Indeed, live cell imaging of cell lines stably expressing 
mRFP-tagged Histone H2B revealed the frequent occurrence of chromosome mis-segregation 
events in all HGSC cell lines (Figure 1e,f). Chromosome segregation errors were further 
examined using high-resolution imaging of fixed cells to gain insights about the nature of mis-
segregating chromatin (Figure g-i). Anaphase lagging chromatin was sometimes negative for 
CREST-reactive serum (marks centromeric proteins) and Hec1 kinetochore proteins, suggesting 
that some mis-segregation events were precipitated by structural chromosome alterations 
(Figure 1g,i,j). To verify the acentric nature of lagging chromatin, we performed FISH using 
all-centromere-targeted probes in the G33 cell line. This confirmed the presence of mis-
segregating chromatin devoid of centromeric DNA sequence (Figure 1k,l). We were struck by 
the high frequency of chromosome mis-segregation in some lines, for example Cov318 exhibited 
errors in 50% of cells, with each cell typically displaying multiple errors, often of different types 
(Figure 1j). HGSC cell lines thus exhibit continual mis-segregation of both intact and 
structurally abnormal chromosomes, contributing to their high rates of numerical and structural 
CIN.  
 
HGSC cell lines exhibit pronounced chromosome congression delays, a functional mitotic 
checkpoint and normal sister chromatid cohesion. 
 We next tested whether control of mitosis was perturbed in HGSC, by analysing mitotic 
progression kinetics using live cell imaging. Slight congression delays have been reported in 
colorectal cancer8 but it was hitherto unknown whether this occurs in other cancer types. Four 
HGSC cell lines exhibited significant delays in mitosis, as measured by both the time from 
nuclear envelope breakdown to anaphase onset (Figure 2a,b) and the time from chromosomal 
congression to the metaphase plate (Figure 2c) There was no obvious correlation between higher 
cell line ploidy and slowed congression, suggesting this phenomenon is unconnected with the 
number of chromosomes present. The overall prolonged time in mitosis suggested that 
congression errors were capable of mounting a robust mitotic checkpoint response. Accordingly, 
live cell imaging revealed that all of the four HGSC cell lines tested were able to efficiently 
arrest mitosis following treatment with nocodazole to depolymerise all microtubules (Figure 
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2d). Moreover, immunofluorescence revealed the expected presence of two key mitotic 
checkpoint proteins, Mad2 and BubR1, on uncongressed chromosomes in all cell lines tested 
(Figure S2a,b). Prolonged delays in mitosis have been linked to defective sister chromatid 
cohesion and chromosome mis-segregation32. To evaluate this, we measured inter-centromere 
distance, which provides a measure of sister chromatid cohesion defects33. This suggested 
chromosome cohesion was normal in all HGSC lines with the possible exception of Cov318 
(Figure S2c,d). We note that it was not possible to directly assess cohesion fatigue in these cell 
lines as their slow chromosome congression rates confound these analyses. 
 
Aberrant microtubule assembly rates contribute to chromosome segregation errors in 
HGSC. 
The significant delays in chromosome congression, and the presence of some apparently 
whole (centric), lagging chromosomes in anaphase (Figure 1i, 2c) suggested that the mitotic 
machinery was disrupted in HGSC. Centrosome abnormalities have been detected in ovarian 
cancer27, and can promote the formation of multipolar spindles34. Although multipolar spindles 
can resolve to a pseudo-bipolar spindle in a process known as centrosome clustering35, this can 
elevate the frequency of incorrect chromosome attachments to the spindle and increase 
chromosome segregation errors34,36. We therefore quantified centrosome and spindle defects 
from mitotic cells using antibodies against centrioles (centrosome cores; two per centrosome). 
Most cell lines exhibited a significant percentage of cells with supernumerary (>4) centrioles 
(Figure S3a,b). Cell lines with extra centrosomes also displayed multipolar spindles in 
prometaphase cells (Figure S3c,d). Multipolar spindles usually resolved to pseudo-bipolar 
spindles by anaphase, since most cells underwent bipolar cell division (Figure S3e). To 
investigate whether centrosome amplification was associated with elevated chromosome 
segregation errors in HGSC, we compared error rates between anaphase cells with 4, or more 
than 4 centrioles. In the two lines tested, (G33 and G164), the presence of extra centrosomes 
tended to correlate with a higher rate of chromosome segregation errors, although this was only 
statistically significant for G164 (Figure S3f,g), suggesting a potential small contribution of 
extra centrosomes to CIN in HGSC.  
Elevated microtubule (MT) dynamics leading to delayed chromosome congression, 
chromosome segregation errors and CIN were recently described in colorectal cancer as a result 
of either Aurora A overexpression8 or the deregulation of the Chk2-BRCA1 axis9,37. Our panel 
of HGSC cell lines carries potential Aurora A defects due to a common amplification of the 
chromosomal region carrying the Aurora A gene (AURKA, 20q23; Figure 1a; Figure S3h), that 
	
	 11	
is also common in HGSC tumours23. Indeed, Aurora A levels were upregulated at both 
transcriptional and protein level in all our cell lines (Figure S3i). We therefore tested whether 
MT dynamics were altered in HGSC cell lines, by transiently expressing the MT tip-tracking 
protein EB3 tagged with GFP and filming MT growth. To allow accurate quantification of 
mitotic spindle MT dynamics, this assay was carried out in cells treated with the Eg5 inhibitor 
Monastrol to generate monopolar spindles, as previously described8 (Figure 2e and Movie S1). 
We included the colorectal cancer cell lines HCT116 (CIN-negative) and SW620 (CIN-positive) 
as controls for normal, and elevated MT assembly rates respectively8. MT assembly rates were 
significantly elevated compared to FNE1 cells in all HGSC cell lines except Kuramochi (Figure 
2f) with most lines notably displaying mean MT assembly rates well above CIN-positive SW620 
colorectal cancer cells. We sought to determine whether this phenomenon was causative for CIN 
in HGSC. We treated cells with a low dose of the MT stabilising agent, paclitaxel (Taxol), 
previously demonstrated to suppress MT assembly rates in colorectal cancer cell lines8. It has 
been previously established that monopolar mitotic spindles frequently orient asymmetrically 
when MT assembly is elevated38, thus providing a proxy read out for elevated MT assembly 
rates. All seven HGSC lines demonstrated asymmetric monopolar spindles at a higher incidence 
than the FNE2 control, which was reduced when cells were treated with low dose paclitaxel 
(Figure 2g, h), and rescue of abnormal MT dynamics was directly confirmed for two cell lines 
using the EB3-GFP tip tracking assay (Figure 2i). Reducing abnormal MT dynamics also 
reduced chromosome segregation errors in all five HGSC cell lines tested (Figure 2j,k) 
independent of any effect on proliferation (Figure S3j), similar to the effect in colorectal cancer 
cell lines8. This demonstrates that, for this HGSC cell line panel, aberrant MT dynamics 
contribute to chromosome mis-segregation and that low dose paclitaxel represents a viable 
strategy for experimentally reducing CIN in HGSC. 
 
Replication stress contributes to chromosome mis-segregation and CIN in HGSC  
Replication stress, the slowing or stalling of DNA replication, is known to occur in 
multiple cancer types39,40 and was previously shown to contribute to CIN in colorectal cancer by 
generating acentric fragments and chromatin bridges11. The presence of acentric lagging 
chromatin, structural chromosome defects, and the known roles of homologous recombination 
proteins frequently mutated in HGSC (such as BRCA1 and BRCA2) in protecting the DNA 
replication fork41-43, suggested that HGSC cell lines may experience replication stress. To test 
this, we directly examined replication fork speed using single DNA fibre pulse-labelling. All 
HGSC cell lines exhibited reduced replication fork rates compared to control FNE1 cells (Figure 
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3a). We next examined whether this reduced fork speed would correlate with known hallmarks 
of replication stress, namely; elevated prometaphase DNA damage as indicated by gH2AX foci, 
53BP1 bodies in G1 cells and ultrafine anaphase bridges11,44. Most cell lines exhibited elevated 
levels of gH2AX, but increased levels of ultrafine bridges or formation of 53BP1 bodies were 
seen in only a few cell lines (Figures 3b-d).  
We next examined whether elevated replication stress contributes to chromosome mis-
segregation and CIN in HGSC, by reducing replication stress using nucleoside supplementation 
as previously described11,45. This reproducibly reduced segregation errors compared to untreated 
cells in three cell lines (Ovsaho, Cov318 and G164). By contrast, Snu119, Kuramochi and G33 
were overall non-responsive (Figure 3e,f, S4). To test whether suppression of replication stress 
could translate into a reduction in karyotypic heterogeneity, we grew colonies from single cells 
and performed centromeric FISH to measure within-clone deviation in centromere number. 
Replication stress does not generally induce whole chromosome mis-segregation, and can cause 
preferential mis-segregation of specific chromosomes46. Moreover, HGSC cell lines frequently 
demonstrated multiple error types per cell (Figure 1j) and we therefore expected a weak, if any, 
reduction in centromere number deviation. Nonetheless, Ovsaho and Kuramochi displayed 
reduced karyotypic heterogeneity for one or both chromosomes scored following single cell 
colony derivation in the presence of nucleosides (Figure 3g,h). Cov318 did not show a reduction 
in colony mode deviation despite reduced chromosome segregation errors. Effects of nucleoside 
supplementation on chromosome segregation and karyotypic heterogeneity were independent of 
any effects on proliferation (Figure S3j). Taken together, these data demonstrate the presence 
of replication stress that contributes, in at least a subset of lines, to chromosome segregation 
errors and CIN in HGSC. However, the manifestation of the canonical hallmarks of replication 
stress, and the response to nucleoside supplementation, varied between cell lines. 
We wondered if this variation could be explained by differences in responses to replication 
stress. We tested this by treating cells with low doses of the DNA polymerase poison aphidicolin 
to provide exogenous replication stress44. Cov318 cells had high basal levels of 53BP1 bodies 
that were further elevated in response to aphidicolin, whereas Kuramochi, Ovkate and G33 cells 
failed to recruit 53BP1 in response to both their endogenous and exogenous replication stress 
(Figure 3c,i,j). This suggests that some HGSC cell lines may either have an increased capacity 
to repair stalled forks before they result in damage, or a failure in labelling replication stress-





Differences in CIN mechanisms can indicate responses to HGSC therapeutics.  
PARP inhibitors recently emerged as a new therapy to treat cancers with homologous 
recombination repair deficiencies (HRD) caused by mutations in HR genes such as BRCA1/247. 
Given that many of the HGSC cell lines demonstrated replication stress that might result in 
increased stalled forks, we wondered if this might result in sensitivity to PARP inhibitors. We 
therefore treated all cell lines with a range of olaparib doses and monitored cell growth using 
IncuCyte® cellular imaging (Figure 4a). Most HGSC cell lines demonstrated similar sensitivity 
to FNE1 cells (proliferation reduced by 50% at 1-10µM olaparib). However, G33 and Ovkate 
were more resistant suggesting a differential HR capability between these and the other HGSC 
cell lines. We therefore directly tested cellular responses to ionising radiation using a Rad51 
focus formation time-course assay, a common measure of HR efficiency48,49 (Figure 4b). FNE1 
cells showed an increase in Rad51 foci within two hours, and by 24 hours, foci began to decrease 
in number (Figure 4c). This pattern was recapitulated in all HGSC cell lines, with the notable 
exception of G33, that showed a marked delay in formation of Rad51 foci (Figure 4c). 
Collectively these data suggest that the relative resistance of G33 and Ovkate to olaparib was 
not due to HRD-induced sensitivity in the other cell lines. A delayed Rad51 response in G33 
cells may therefore reflect a general failure of replication stress and/or DNA damage response 
rather than HR capability directly. We observed reduced replication stress responses (such as 
low gH2AX and 53BP1 foci despite reduced replication fork speeds, and failure to induce 53BP1 
foci upon aphidicolin treatment) in G33 and Ovkate (see Figure 3b,c,j). We suggest that an 
attenuated replication stress response might therefore serve as a novel indicator of resistance to 
PARP inhibitor therapy. 
Paclitaxel is a mainstay chemotherapy agent used to treat HGSC patients, but can be very 
neurotoxic50. There are currently no biomarkers for which patients would benefit most from 
paclitaxel as a chemotherapy. Since paclitaxel stabilises MTs, we reasoned that cell lines with 
elevated MT assembly rates might be inherently resistant to paclitaxel. Indeed, Kuramochi, the 
cell line that exhibits near-normal MT assembly rates (see Figure 2f) was the most sensitive to 
paclitaxel, with a proliferation response similar to FNE1 and FNE2 (Figure 4d). Other cell lines 
showed increasing resistance to paclitaxel that positively correlated with their MT assembly 
rates although this did not reach significance (Figure 4e). This suggests that methods to assess 
elevated MT assembly rates in cancer patient samples could be further explored as an indicator 




Genetic and transcriptomic analyses reveal potential causative CIN genes.  
Given the links between functional CIN readouts and chemotherapy sensitivities we were 
motivated to thoroughly assess whether genomic, genetic or transcriptomic analyses (more 
readily available from patient samples) might indicate these key CIN features, and also shed 
light on the precise deregulated pathways culminating in the observed functional phenotypes. 
For this purpose, we performed single nucleotide variant (SNV) calling using the Genome 
Analysis Toolkit (GATK) workflow, utilizing a Panel of Normals (PoN) to stringently remove 
common single nucleotide polymorphisms (SNPs), as matched normal samples were not 
available. We thus identified a list of likely somatic mutations (Table S2;Figure S5a). Most cell 
lines carried two to seven potentially CIN-related mutations, however none of these obviously 
co-segregated with specific phenotypes (Figure S5a). G33 bore thirteen mutations in potential 
CIN-genes, although the overall genome mutation rate was similar to the other HGSC cell lines 
(Figure S5b). Next, we analysed the transcriptome of each cell line using RNA sequencing. We 
collated all significantly altered CIN-related genes (Table S3;Figure S5c). Of these, RB1, 
TopBP1, CCNE1 (Cyclin E), and genes from MCM and GINS DNA replication complexes were 
frequently deregulated (Figure S5c). We noted that G33 was the only cell line to show 
significant elevated expression of 53BP1. We also looked for gene expression changes that were 
linked to particular phenotypes. For PARP inhibitor resistance (Figure 4a), we examined genes 
whose expression was altered (relative to both FNE1 and 2) in both Ovkate and G33, but not 
altered in the five HGSC cell lines that showed olaparib sensitivity (Figure S5d). We found no 
statistically significant gene ontology pathway enrichment, however we did note that there were 
five significantly altered genes with DNA replication and repair functions (Figure S5d). One of 
these was TLK1, a kinase responsible for assembly of nucleosomes on replication forks with a 
potential role in PARP inhibitor response51. Similarly, an analysis of the cell lines with strongest 
paclitaxel resistance (Figure 4d) revealed a cluster of eight genes involved in microtubule 
regulation, and five DNA replication-related genes were commonly altered in cell lines with an 
attenuated response to replication stress (Figure S5d). When comparing between cell lines with 
differential responses to nucleoside-mediated segregation error rescue (Figure 3f), we found an 
enrichment in genes regulating nucleotide metabolism, which might explain why some cell lines 
had better CIN reduction than others. For the congression defects observed in four cell lines 
(Figure 2c), the most relevant significantly enriched pathway was actin cytoskeleton 
reorganisation (Figure S5d). As well as concentrating on known CIN-related pathways, we also 
identified the significantly altered genes and pathways in those HGSC cell lines sharing specific 
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CIN phenotypes, analysed independently from the FNE controls (Figure S6a,b, Table S4). 
Overall genetic and transcriptomic analysis did not reveal any clear causative pathways to CIN, 
but these data provide a resource for future identification of genes related to those phenotypes, 
and to potentially identify novel roles in CIN for other genes.  
 
Discussion 
Here we have performed the first systematic and comprehensive functional analysis of 
mechanisms driving chromosomal instability in a panel of representative HGSC cell lines. All 
seven lines demonstrate extensive ongoing CIN in the form of chromosome mis-segregation that 
is associated with multiple mechanisms, including elevated microtubule assembly rates, 
centrosome amplification, and replication stress (see Figure 5 for a summary and correlations 
between phenotypes across all cell lines). A striking finding of our study is that compared to 
colorectal cancer cell lines, HGSC cell lines exhibit a greater number of co-operating CIN 
mechanisms, and each CIN mechanism often operates at more extreme levels (for example 
slower replication fork rates and higher MT assembly rates than colorectal cancer cell lines). 
Moreover, multiple CIN mechanisms likely exist within single HGSC cells as evidenced by the 
presence of chromosome segregation errors of multiple types per cell (Figure 1g-j). This 
complexity explains the partial reductions in CIN obtained using CIN limiting experiments (low 
dose paclitaxel and nucleoside supplementation), and will be important to consider when 
designing approaches to target CIN therapeutically in this disease. We also noted that HGSC 
lines were not entirely uniform in the extent to which each CIN mechanism was manifested. 
Interestingly we discovered that these differences in characteristics or severity of specific CIN 
mechanisms were related to sensitivity to paclitaxel and PARP inhibition, mainstays of HGSC 
treatment. Whole genome sequencing and transcriptomic analysis revealed potential genetic 
drivers of CIN in HGSC that can be harnessed in future mechanistic studies. Given these findings 
we suggest that assessing CIN mechanisms in HGSC patients either functionally or by 
association with specific mutational or transcriptomic signatures may provide new biomarkers 
to predict sensitivity to paclitaxel and PARP inhibitors.  
Centrosome amplification has been observed in many cancer types, although its origin is 
still unclear. Whole genome doubling (WGD) events caused by cytokinesis failure could 
generate both centrosome amplification and increases in chromosome ploidy. Indeed, WGD is 
estimated to occur particularly frequently in HGSC52. However, many cells exhibited centriole 
numbers exceeding eight (the expected consequence of cytokinesis failure) (Figure S3g) and 
some centrosome amplified lines were close to diploid (e.g. Kuramochi), suggesting potential 
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alternative routes to centrosome amplification. One such cause could be replication stress itself, 
since slow replication can cause extra centrosomes53. Centrosome amplification correlated with 
increased segregation errors in the cell lines tested, but cells with normal centriole numbers also 
exhibited high error rates, suggesting this is not the main driver of CIN in HGSC (Figure S3f).  
Most HGSC lines displayed defects in chromosome congression, and all cell lines except 
Kuramochi exhibited markedly elevated microtubule assembly rates. Notably, all of the cell lines 
we tested demonstrated significantly reduced segregation errors after treatment with low doses 
of paclitaxel to restore aberrant MT assembly (Figure 2k) suggesting this is a major contributor 
to HGSC CIN.  In colorectal cancer, elevated MT assembly rates are proposed to occur as a 
result of overactive Aurora kinase A9,37 or a deregulated BRCA1-Chk2 axis8,9. None of our eight 
cell lines exhibited BRCA1 point mutations. Some lines displayed evidence of partial BRCA1/2 
copy number loss but we saw no significant reduction in BRCA1/2 expression at the RNA level 
except in Ovsaho (Figure S1g,j, S5c). All lines except Snu119 however, displayed copy number 
gain of the AURKA locus (Figure S3h,i), and all cell lines showed Aurora Kinase A 
overexpression at mRNA and protein level, suggesting that in this panel at least, AURKA gene 
amplification may be a key driver of MT over-assembly, mitotic abnormalities and CIN in 
HGSC. However, despite displaying Aurora Kinase A upregulation, Kuramochi did not exhibit 
significantly elevated MT assembly rates. Kuramochi was also notably the most sensitive to 
higher, clinically-relevant doses of paclitaxel. Discovering the cause of these differential 
phenotypes and whether functional biomarkers could be derived (such as a clinical measure of 
MT assembly rates) may lead to the first clinical biomarker for paclitaxel sensitivity.  
It is also possible that other genetic lesions could generate elevated MT assembly rates, 
for example DNA-PKcs has recently been identified as upstream of the BRCA1-Chk2 axis54. 
Cep72 has been implicated in MT assembly defects41 and is significantly overexpressed in 
Ovkate. Moreover, comparison of transcriptomic features of cell lines that were most affected 
by congression delays identified an enrichment of eleven genes in actin reorganisation, that 
might indicate a systemic cytoskeletal defect. Supernumerary centrosomes could also contribute 
to elevated MT assembly rates as a result of increased MT nucleation55, suggesting the intriguing 
possibility that extra centrosomes might mediate chromosome mis-segregation via mechanisms 
over and above their canonical role in promoting abnormal geometry during spindle formation. 
Lastly, a connection between replication stress and elevated MT assembly rates has also been 
described in colorectal cancer 56 and it would be interesting to examine this further in HGSC. 
Alongside mitotic defects, all seven HGSC cell lines also exhibited some degree of 
replication stress, as evidenced from single molecule DNA fibre analysis and other hallmarks of 
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replication stress. Oncogene-induced replicative and mitotic stress can result from a myriad of 
known oncogenes and tumour suppressor genes57,58 however HGSC harbours relatively few 
recurrent mutations. Similarly, our panel of cell lines shared few mutations in common (Figure 
S5a), with the exception of TP53. Cyclin E has been noted as a common defect in HGSC20. Five 
cell lines showed CCNE1 amplification at gene level, six had significantly increased RNA 
expression and all showed increased protein expression (Figure S1i); however this did not seem 
to correlate with any of the specific replication stress phenotypes we investigated herein and 
may simply play a role in promoting replication stress and CIN in general in HGSC59 (Figure 
5). Replication stress has been successfully treated with exogenous nucleoside supplementation 
in a variety of models11,45,60,61. We found that nucleosides had a positive, or at worst only neutral, 
effect on segregation errors in HGSC cell lines. Crucially we saw no negative effect in the FNE1 
control. This suggests that nucleoside supplementation could be investigated further, perhaps as 
a prophylactic treatment for women with familial risk of developing HGSC, or given alongside 
therapy in order to reduce the likelihood of developing treatment-resistant disease.  
Unexpectedly, many of the cell lines did not entirely follow the canonical response11,44 to 
replication stress. G33 and Ovkate were among those cell lines particularly unusual in lacking 
multiple replication stress markers including gH2AX and 53BP1 bodies and when further 
challenged with aphidicolin, both remained incapable of mounting a DNA damage response 
(Figure 3b,c,j). Strikingly, these two cell lines were resistant to PARP inhibition compared to 
other cell lines and the FNE controls. Moreover, this was connected, in the case of G33, to a 
defective Rad51 recruitment to IR-induced DNA damage which would normally be taken to 
indicate HR deficiency. All other cell lines recruited Rad51 with normal kinetics. In line with 
this there was no significant loss of expression at RNA level of known HR genes (except for 
RAD51D in Kuramochi and BRCA2 in Ovsaho; Figure S5c) despite the reduced copy number 
of BRCA1 and 2 in multiple cell lines and the known mis-sense mutation detected in 
Kuramochi23 (Figure S1g,j, S5a,c). Originally the success of PARP inhibitors was attributed to 
the synthetic lethality involved in disabling the break excision repair function of the PARP 
pathway, leaving HRD tumours unable to repair single stranded DNA breaks. More recent work 
has pointed to an increased complexity of possible mechanisms, with PARP inhibition resulting 
in stalled replication forks that cannot be restarted in a BRCA-minus background, and thus 
become vulnerable to degradation due to excessive MRE11 nuclease activity62. New ‘backup’ 
pathways have also been described in cancer cells, such as reliance on Rad52 to promote Rad51 
loading in BRCA-deficient cells63, or the downregulation of PTIP to reduce MRE11 
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recruitment62. Since replication stress is also likely to result in stalled forks that need repair or 
restart, these different pathways to stalled fork resolution may also underpin the variation in 
replication stress response observed within our HGSC cell line panel. It will be interesting to 
test whether inhibition of Rad52 would re-sensitise G33 and Ovkate to PARP inhibition. These 
studies, alongside our findings that G33’s delayed Rad51 focus formation correlated with PARP 
inhibition resistance rather than sensitivity, suggest that consideration of replication stress levels 
and responses may also need to be taken into consideration when predicting clinical PARP 
inhibitor sensitivity, and when interpreting functional assessments of HR competency.  
G33 carried the highest number of mutations in known CIN-related genes (Figure S5a). 
We also noted that G33 was the only cell line to show elevated gene expression of 53BP1 despite 
an inability to form 53BP1 bodies (Figure 3j, S5c), which might lead to an imbalance in the 
non-homologous end joining/HR responses to DNA damage and contribute to PARPi resistance. 
Intriguingly, G33 is also the only cell line with significant loss of p53 expression at both RNA 
(Figure S5c) and protein (Figure S1h) levels, whereas the other cell lines expressed mutant 
alleles of full length or truncated (Ovsaho) protein. Loss of p53 expression has previously been 
linked with aberrant Rad51 recruitment64 and G33’s non-sense allele (W146*) has been 
observed in a subset of HGSC patients65. It would be worth investigating the extent to which this 
mutation plays a role in G33’s unique phenotypes both experimentally and in clinical datasets.  
The lack of matched normal patient DNA samples made some genetic analyses difficult. 
Herein we used various approaches to circumvent this issue. However, future studies will benefit 
from the acquisition of patient-specific matched normal DNA samples to permit more extensive 
analyses to link genotype to CIN phenotypes. Another potential caveat of this study is that there 
may be differences in the behaviour of cell line models compared to cells within tumours in 
patients. To mitigate against this, we selected a panel of HGSC cell lines whose genetic and 
genomic features recapitulated HGSC tumours23-25. We also enhanced the strength of our 
analysis by comparing our RNA expression profiles and CIN phenotypes not just between cancer 
cell lines but also against two appropriate, tissue-specific control cell lines. Moreover, the 
behaviour of this cell line panel was notably different to previously characterised colorectal 
cancer cell line panels that did not display overt chromosome congression delays or 
supernumerary centrosomes8,11. Therefore, tumour-derived cell lines still represent the best 
currently available model to functionally connect genetic lesions, genomic alterations and CIN 
mechanisms. Moreover, a landmark study has recently shown extensive cell division 
abnormalities from patient-derived HGSC cancer cells, at similar rates to what we have observed 
in our cell lines15. This provides an important complementary validation of our findings, and 
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suggests the CIN mechanisms identified herein are likely to be bona fide HGSC CIN 
mechanisms, that can be validated in vivo in future studies.  
This study provides new understanding of the nature of CIN in HGSC, is directly 
comparable to existing knowledge of CIN mechanisms in other cancer types, and moreover lays 
the groundwork for future studies to validate mechanisms driving HGSC CIN in vivo. Our 
findings also have the potential to facilitate future research into synergising with patient-specific 
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Figure 1: HGSC cell lines display numerical and structural chromosome defects and 
persistent chromosome segregation errors. A) DNA copy number profiles computed from 
whole genome sequencing data for HGSC cell lines. B) Representative image of a metaphase 
spread from Ovsaho. Pan-centromere FISH staining indicated in green (panCEN); scale bar 10 
µm. C) Ploidy of each cell line was derived from metaphase spread analysis. For each cell line, 
twenty metaphase spreads were analysed across two experiments. D) M-FISH analysis of 
metaphase spreads showing structural and numerical aberrations from FNE1 and Kuramochi. E) 
Stills taken from movies of Ovsaho cells stably expressing H2B-RFP (white). Time in minutes 
is indicated post nuclear envelope breakdown (NEBD). Arrowhead indicates chromatin bridge. 
F) Chromosome segregation error rates from live cell movies. Data shown is from two 
independent experiments. G) Immunofluorescence images of anaphase cells probed with 
antibodies to CREST (red, marks centromere) and Hec1 (green, marks kinetochore) exhibiting 
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different classes of segregation errors; lagging centric, lagging acentric, anaphase bridge. H) 
Analysis of segregation errors of all cell lines from immunofluorescence images, from four to 
seven experiments (179-300 anaphase cells per cell line). I) Anaphase cells with errors from H 
were classified according to error type (either centric, acentric or bridge errors or a mixture of 
any or all three types). J) Cov318 anaphase cells with multiple errors, and error types, per cell. 
K,L) FISH with centromeric probes (PanCEN; green) was used to define whether lagging 
chromatin (red) was positive (centric) or negative (acentric) for DNA centromere sequence, 
quantified in (L) for 108 anaphases in G33 cell line.  
 
Figure 2: HGSC cell lines prolong mitosis due to slow alignment of chromosomes to the 
metaphase plate; low dose paclitaxel can reduce MT dynamics and CIN. A) Stills from 
movies of cell lines stably expressing H2B-RFP (white). Time in minutes is indicated post 
nuclear envelope breakdown (NEBD). Frames where the last chromosome completed 
congression to the metaphase plate (LCC) and where anaphase onset (AO) began, are indicated. 
Scale bar represents 5 µm. B) Time taken for cells to progress from NEBD to anaphase onset. 
Each circle represents timing for one cell. Data taken from two independent experiments; 22-
126 cells analysed per cell line in total. Statistical difference between HGSC cancer cell lines 
and FNE1 control is indicated (one-way ANOVA with Dunnett’s correction for multiple testing). 
C) Time taken for cells to progress from NEBD to last chromosome congressed (LCC) to the 
metaphase plate. Data taken from two independent experiments. 26-109 cells analysed per cell 
line in total. Statistical test as in (B). Differences between HGSC cancer cell lines compared to 
FNE1 are shown. D) Length of time cells remained arrested in mitosis after treatment with 
nocodazole, to assess Spindle Assembly Checkpoint. Summary of one (Snu119, FNE1), two 
(Cov318, Kuramochi) or three (G164) experiments. E) Stills from live movies of cells 
expressing EB3-GFP, arrested in mitosis using monastrol. F) Analysis of microtubule dynamics 
from EB3-GFP live imaging tip tracking assay. Statistical test performed as in (B). G) 
Prometaphase cells arrested with monastrol, showing normal symmetric (HCT116) or abnormal 
asymmetric (Cov318) spindle morphology. H) Quantification of abnormal spindle morphology 
in cells arrested with monastrol in conjunction with 0, 1 or 2 nM paclitaxel. I) Microtubule 
assembly rates in cells expressing EB3-GFP, arrested with monastrol and treated with either 
DMSO or 1 nM paclitaxel. J, K) Segregation error rates of cells after 2 hr treatment with DMSO 
or 1 nM paclitaxel. T-tests were performed in I) and K) between pairs as indicated. Scale bars 5 
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(in A) or 10 µm (in G). Asterisks denote significance (*p<0.05, **p<0.01, ***p<0.001 
****p<0.0001, or non-significant (p>0.05; ns)).  
 
Figure 3: HGSC cell lines exhibit replication stress that contributes to chromosome mis-
segregation and CIN. A) Histograms for replication fork rates as measured by DNA fibre assays 
(99-202 fibres analysed in total for each cell line; examples of fibres shown on right, with 
average calculated speed). CIN-positive SW620 and CIN-negative HCT116 colorectal cancer 
cell lines were used as controls for slow, and normal replication fork rates respectively.  B) 
Example immunofluorescence (IF) image of prometaphase cell stained for gH2AX. 
Quantification given below image. C) Example of IF image of a G1 (Cyclin A negative) cell 
stained for 53BP1 bodies, with quantification. D) Example IF image of an anaphase cell with an 
ultrafine bridge as demonstrated by a DAPI-negative, RPA bridge, with quantification. 
Statistical tests for (b-d) are one-way ANOVA with Dunnett’s correction for multiple testing 
using FNE1 as control. E, F) Segregation error rates of cells treated with nucleosides, given as 
fold change of errors in untreated cells (see Figure S4 for raw data). Significance from t-test for 
each treated/untreated pair is indicated. G) Examples of clonal FISH images, with cells stained 
for probes against centromere enumeration probes (CEP) of chromosomes 3 (CEP3; red) and 6 
(CEP6; green). H) Analysis of numerical CIN using clonal FISH without or with nucleoside 
treatment. For each cell line, each circle indicates percentage of cells in a colony deviating from 
modal value (modes given below graph) of that chromosome in that colony. T-test between pairs 
is shown. I, J) 53BP1 bodies in Cyclin A-negative (G1) cells were quantified in cells treated for 
24 hr with DMSO or aphidicolin (0.2 µM). Summary of two experiments, n=65-187 cells. 
Asterisks denote significance (*p<0.05, **p<0.01, ***p<0.001 ***p<0.0001, or non-significant 
(ns)). Green bars in B,C,D,H,J indicate mean. Scale bars represent 5 µm in all images, except 
20 µm in (G). 
 
Figure 4: HGSC response to chemotherapy. A) Proliferation dose response to PARPi. Dotted 
line indicates where proliferation dropped below 50% of DMSO treated cells. Mean and standard 
deviation from three independent experiments is shown. B) FNE1 cells (untreated or 2 hr 
recovery after irradiation with 2 Gy) stained for Rad51 and Cyclin A. Scale bar represents 5 µm. 
C) Quantification of Rad51 foci in S/G2 cells (Cyclin A positive) in untreated cells or in cells 
with 2 hr or 24 hr recovery from irradiation with 2 Gy. Red line indicates mean from three 
independent experiments. D) Proliferation dose response to paclitaxel. Dotted line indicates 
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where proliferation dropped below 50% of DMSO treated. Mean and standard deviation from 
three independent experiments (one for Ovkate). E) Correlation between microtubule assembly 
rates (from Figure 2f) and paclitaxel resistance (approximate value for paclitaxel dose causing 
proliferation to drop to 50% of DMSO controls, as a log scale, taken from Figure 4d) in HGSC 
cell lines. Pearson’s correlation with p-value indicated.  
 
Figure 5 (relating to Discussion): Phenotype summary. (A) Clustering of HGSC cell lines 
according to extent of their functional CIN phenotypes. (B) Relationships between different CIN 
phenotypes in this study; Pearson’s Correlation and p-value given for each.  
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